AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
Although patients benefit from surgical transurethral resection of bladder cancers, some niduses are missed or incompletely resected, and small malignant lesions may recur. Intravesical chemotherapy and immunotherapy are universally accepted as adjuvant treatments after surgery to avoid recurrence and progression. However, these treatments still have limitations, including an insufficient retention period, inefficient permeability of chemotherapeutic agents, and dilution of the agents by urine. Nanostructure-based smart therapeutic platforms can be tailored to be responsive to internal or external stimuli to ameliorate this situation. This unparalleled capability empowers the precise aggregation of stimulus–responsive nanocarriers in the target regions, namely, the tumors, and subsequent release of the anticancer materials. This review summarizes the current nanostructure-based therapeutic platforms, especially stimulus–responsive nanocarriers, and highlights their benefits and limitations in bladder cancer therapy. Novel innovations in nanotechnology have undoubtedly arrived at a new height and have become useful for practical applications. Nanotechnology will positively promote the development of anticancer agents not only for bladder cancer but also for other solid tumors.
Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer statistics, 2020. CA: Cancer J. Clin. 2020, 70, 7–30.
Naito, S.; Algaba, F.; Babjuk, M.; Bryan, R. T.; Sun, Y. H.; Valiquette, L.; de la Rosette, J.; on behalf of the CROES Narrow Band Imaging Global Study Group. The clinical research office of the endourological society (CROES) multicentre randomised trial of narrow band imaging-assisted transurethral resection of bladder tumour (TURBT) versus conventional white light imaging-assisted turbt in primary non-muscle-invasive bladder cancer patients: Trial protocol and 1-year results. Eur. Urol. 2016, 70, 506–515.
Pandey, R.; Jackson, J. K.; Liggins, R.; Mugabe, C.; Burt, H. M. Enhanced taxane uptake into bladder tissues following co-administration with either mitomycin C, doxorubicin or gemcitabine: Association to exfoliation processes. BJU Int. 2018, 122, 898–908.
Lenis, A. T.; Lec, P. M.; Chamie, K.; Mshs, M. D. Bladder cancer: A review. JAMA 2020, 324, 1980–1991.
Eaton, A. F.; Clayton, D. R.; Ruiz, W. G.; Griffiths, S. E.; Rubio, M. E.; Apodaca, G. Expansion and contraction of the umbrella cell apical junctional ring in response to bladder filling and voiding. Mol. Biol. Cell 2019, 30, 2037–2052.
Tyagi, P.; Wu, P. C.; Chancellor, M.; Yoshimura, N.; Huang, L. Recent advances in intravesical drug/gene delivery. Mol. Pharm. 2006, 3, 369–379.
Soler, R.; Bruschini, H.; Martins, J. R.; Dreyfuss, J. L.; Camara, N. O.; Alves, M. T.; Leite, K. R.; Truzzi, J. C.; Nader, H. B.; Srougi, M. et al. Urinary glycosaminoglycans as biomarker for urothelial injury: Is it possible to discriminate damage from recovery? Urology 2008, 72, 937–942.
GuhaSarkar, S.; Banerjee, R. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. J. Control. Release 2010, 148, 147–159.
Petros, R. A.; DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9, 615–627.
Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46, 6387–6392.
Smith, A. M.; Duan, H. W.; Mohs, A. M.; Nie, S. M. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev. 2008, 60, 1226–1240.
Ma, Z. R.; Wan, H.; Wang, W. Z.; Zhang, X. D.; Uno, T.; Yang, Q. L.; Yue, J. Y.; Gao, H. P.; Zhong, Y. T.; Tian, Y. et al. A theranostic agent for cancer therapy and imaging in the second near-infrared window. Nano Res. 2019, 12, 273–279.
Moulin, E.; Faour, L.; Carmona-Vargas, C.; Giuseppone, N. From molecular machines to stimuli-responsive materials. Adv. Mater. 2020, 32, 1906036.
Shi, J. J.; Kantoff, P. W.; Wooster, R.; Farokhzad, O. C. Cancer nanomedicine: Progress, challenges and opportunities. Nat. Rev. Cancer 2017, 17, 20–37.
Karimi, M.; Ghasemi, A.; Sahandi Zangabad, P.; Rahighi, R.; Moosavi Basri, S. M.; Mirshekari, H.; Amiri, M.; Shafaei Pishabad, Z.; Aslani, A.; Bozorgomid, M. et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem. Soc. Rev. 2016, 45, 1457–1501.
Fosgerau, K.; Hoffmann, T. Peptide therapeutics: Current status and future directions. Drug Discov. Today 2015, 20, 122–128.
Wang, H. M.; Feng, Z. Q. Q.; Xu, B. Assemblies of peptides in a complex environment and their applications. Angew. Chem., Int. Ed. 2019, 58, 10423–10432.
Guo, H.; Hou, Y. C.; Ding, J. X. Nanomedicines for intravesical chemotherapy in bladder cancer. Curr. Pharm. Des. 2019, 25, 371–373.
Guo, H.; Li, F. P.; Qiu, H. P.; Xu, W. G.; Li, P. Q.; Hou, Y. C.; Ding, J. X.; Chen, X. S. Synergistically enhanced mucoadhesive and penetrable polypeptide nanogel for efficient drug delivery to orthotopic bladder cancer. Research 2020, 2020, 8970135.
Galluzzi, L.; Senovilla, L.; Zitvogel, L.; Kroemer, G. The secret ally: Immunostimulation by anticancer drugs. Nat. Rev. Drug Discov. 2012, 11, 215–233.
Feng, X. R.; Xu, W. G.; Liu, J. H.; Li, D.; Li, G.; Ding, J. X.; Chen, X. S. Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy. Sci. Bull. 2021, 66, 362–373.
Wang, H. M.; Feng, Z. Q. Q.; Qin, Y. N.; Wang, J. Q.; Xu, B. Nucleopeptide assemblies selectively sequester ATP in cancer cells to increase the efficacy of doxorubicin. Angew. Chem., Int. Ed. 2018, 57, 4931–4935.
Liu, H. X.; Mei, C. M.; Deng, X. R.; Lin, W. Q.; He, L. Z.; Chen, T. F. Rapid visualizing and pathological grading of bladder tumor tissues by simple nanodiagnostics. Biomaterials 2021, 264, 120434.
Wang, H. M.; Feng, Z. Q. Q.; Xu, B. Supramolecular assemblies of peptides or nucleopeptides for gene delivery. Theranostics 2019, 9, 3213–3222.
Wang, H. M.; Feng, Z. Q. Q.; Lu, A.; Jiang, Y. J.; Wu, H.; Xu, B. Instant hydrogelation inspired by inflammasomes. Angew. Chem., Int. Ed. 2017, 56, 7579–7583.
Li, G. Z.; Lei, Q. F.; Wang, F.; Deng, D. S.; Wang, S. P.; Tian, L. L.; Shen, W. W.; Cheng, Y. Y.; Liu, Z.; Wu, S. Fluorinated polymer mediated transmucosal peptide delivery for intravesical instillation therapy of bladder cancer. Small 2019, 15, 1900936.
Brisuda, A.; Ho, J. C. S.; Kandiyal, P. S.; Ng, J. T. Y.; Ambite, I.; Butler, D. S. C.; Háček, J.; Wan, M. L. Y.; Tran, T. H.; Nadeem, A. et al. Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex. Nat. Commun. 2021, 12, 3427.
Qiu, H. P.; Guo, H.; Li, D.; Hou, Y. C.; Kuang, T. R.; Ding, J. X. Intravesical hydrogels as drug reservoirs. Trends Biotechnol. 2020, 38, 579–583.
Chatta, D.; Cottrell, L.; Burnett, B.; Laverty, G.; McConville, C. The use of water-soluble mucoadhesive gels for the intravesical delivery of epirubicin to the bladder for the treatment of non-muscle-invasive bladder cancer. J. Pharm. Pharmacol. 2015, 67, 1355–1362.
Huang, Z. M.; Xiao, H.; Lu, X. Y.; Yan, W. G.; Ji, Z. G. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel. Int. J. Nanomedicine 2018, 13, 7623–7631.
van Valenberg, F. J. P.; Strauss-Ayali, D.; Agmon-Gerstein, Y.; Friedman, A.; Arentsen, H. C.; Schaafsma, H. E.; Witjes, J. A.; Oosterwijk, E. Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model. Ther. Adv. Urol. 2018, 10, 213–221.
Jaiswal, M. K.; Pradhan, L.; Vasavada, S.; De, M.; Sarma, H. D.; Prakash, A.; Bahadur, D.; Dravid, V. P. Magneto-thermally responsive hydrogels for bladder cancer treatment: Therapeutic efficacy and in vivo biodistribution. Colloids Surf. B 2015, 136, 625–633.
Liu, C. W.; Wu, Y. T.; Lin, K. J.; Yu, T. J.; Kuo, Y. L.; Chang, L. C. A hydrogel-based epirubicin delivery system for intravesical chemotherapy. Molecules 2016, 21, 712.
GuhaSarkar, S.; More, P.; Banerjee, R. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery. J. Control. Release 2017, 245, 147–156.
Sun, X. L.; Sun, P.; Li, B.; Liu, Y. Q.; Wang, M. W.; Suo, N.; Yang, M.; Zhang, D.; Jin, X. B. A new drug delivery system for Mitomycin C to improve intravesical instillation. Mater. Des. 2016, 110, 849–857.
Pavan Grandhi, T. S.; Potta, T.; Nitiyanandan, R.; Deshpande, I.; Rege, K. Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation. Biomaterials 2017, 142, 171–185.
Sherif, A. Y.; Mahrous, G. M.; Alanazi, F. K. Novel in-situ gel for intravesical administration of ketorolac. Saudi Pharm. J. 2018, 26, 845–851.
Lin, T. S.; Wu, J. H.; Zhao, X. Z.; Lian, H. B.; Yuan, A. H.; Tang, X. L.; Zhao, S.; Guo, H. Q.; Hu, Y. Q. In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract. J. Pharm. Sci. 2014, 103, 927–936.
Lin, T. S.; Zhang, Y. F.; Wu, J. H.; Zhao, X. Z.; Lian, H. B.; Wang, W.; Guo, H. Q.; Hu, Y. Q. A floating hydrogel system capable of generating CO2 bubbles to diminish urinary obstruction after intravesical instillation. Pharm. Res. 2014, 31, 2655–2663.
Zhu, G. C.; Zhang, Y. F.; Wang, K. K.; Zhao, X. Z.; Lian, H. B.; Wang, W.; Wang, H. R.; Wu, J. H.; Hu, Y. Q.; Guo, H. Q. Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release. Drug Deliv. 2016, 23, 2820–2826.
Goo, Y. T.; Yang, H. M.; Kim, C. H.; Kim, M. S.; Kim, H. K.; Chang, I. H.; Choi, Y. W. Optimization of a floating poloxamer 407-based hydrogel using the Box-Behnken design: In vitro characterization and in vivo buoyancy evaluation for intravesical instillation. Eur. J. Pharm. Sci. 2021, 163, 105885.
Yoon, H. Y.; Chang, I. H.; Goo, Y. T.; Kim, C. H.; Kang, T. H.; Kim, S. Y.; Lee, S. J.; Song, S. H.; Whang, Y. M.; Choi, Y. W. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel. Int. J. Nanomedicine 2019, 14, 6249–6268.
Martin, D. T.; Steinbach, J. M.; Liu, J. C.; Shimizu, S.; Kaimakliotis, H. Z.; Wheeler, M. A.; Hittelman, A. B.; Saltzman, W. M.; Weiss, R. M. Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer. Mol. Cancer Ther. 2014, 13, 71–81.
Mugabe, C.; Matsui, Y.; So, A. I.; Gleave, M. E.; Baker, J. H. E.; Minchinton, A. I.; Manisali, I.; Liggins, R.; Brooks, D. E.; Burt, H. M. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer. Clin. Cancer Res. 2011, 17, 2788–2798.
Mun, E. A.; Williams, A. C.; Khutoryanskiy, V. V. Adhesion of thiolated silica nanoparticles to urinary bladder mucosa: Effects of PEGylation, thiol content and particle size. Int. J. Pharm. 2016, 512, 32–38.
Kaldybekov, D. B.; Filippov, S. K.; Radulescu, A.; Khutoryanskiy, V. V. Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery. Eur. J. Pharm. Biopharm. 2019, 143, 24–34.
Miao, L.; Guo, S. T.; Zhang, J.; Kim, W. Y.; Huang, L. Nanoparticles with precise ratiometric co-loading and co-delivery of gemcitabine monophosphate and cisplatin for treatment of bladder cancer. Adv. Funct. Mater. 2014, 24, 6601–6611.
Kanasty, R. L.; Whitehead, K. A.; Vegas, A. J.; Anderson, D. G. Action and reaction: The biological response to siRNA and its delivery vehicles. Mol. Ther. 2012, 20, 513–524.
Davis, M. E.; Zuckerman, J. E.; Choi, C. H.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464, 1067–1070.
Li, H.; Wang, S. Y.; Ji, Z. X.; Xu, C. C.; Shlyakhtenko, L. S.; Guo, P. X. Construction of RNA nanotubes. Nano Res. 2019, 12, 1952–1958.
Chen, X. H.; Mangala, L. S.; Rodriguez-Aguayo, C.; Kong, X. C.; Lopez-Berestein, G.; Sood, A. K. RNA interference-based therapy and its delivery systems. Cancer Metast. Rev. 2018, 37, 107–124.
Kang, M. R.; Yang, G.; Place, R. F.; Charisse, K.; Epstein-Barash, H.; Manoharan, M.; Li, L. C. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res. 2012, 72, 5069–5079.
Woodrow, K. A.; Cu, Y.; Booth, C. J.; Saucier-Sawyer, J. K.; Wood, M. J.; Saltzman, W. M. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat. Mater. 2009, 8, 526–533.
Liu, J. Y.; Zhang, Y.; Zeng, Q. H.; Zeng, H. L.; Liu, X. M.; Wu, P.; Xie, H. Y.; He, L. Y.; Long, Z.; Lu, X. et al. Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes. Sci. Adv. 2019, 5, eaaw6499.
Wei, S. G.; Gao, J. N.; Zhang, M. P.; Dou, Z. L.; Li, W. S.; Zhao, L. Z. Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer. Biomed. Pharmacother. 2020, 122, 109473.
Erdogar, N.; İskit, A. B.; Eroglu, H.; Sargon, M. F.; Mungan, N. A.; Bilensoy, E. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy. Int. J. Pharm. 2014, 471, 1–9.
Feron, O. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. 2009, 92, 329–333.
Liu, J.; Hebbrecht, T.; Brans, T.; Parthoens, E.; Lippens, S.; Li, C. N.; De Keersmaecker, H.; De Vos, W. H.; De Smedt, S. C.; Boukherroub, R. et al. Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation. Nano Res. 2020, 13, 485–495.
Choi, S. Y. C.; Collins, C. C.; Gout, P. W.; Wang, Y. Z. Cancer-generated lactic acid: A regulatory, immunosuppressive metabolite? J. Pathol. 2013, 230, 350–355.
Harjes, U.; Bensaad, K.; Harris, A. L. Endothelial cell metabolism and implications for cancer therapy. Br. J. Cancer 2012, 107, 1207–1212.
Karimi, M.; Eslami, M.; Sahandi-Zangabad, P.; Mirab, F.; Farajisafiloo, N.; Shafaei, Z.; Ghosh, D.; Bozorgomid, M.; Dashkhaneh, F.; Hamblin, M. R. pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2016, 8, 696–716.
Yang, Y.; Xu, L. G.; Zhu, W. J.; Feng, L. Z.; Liu, J. J.; Chen, Q.; Dong, Z. L.; Zhao, J. Y.; Liu, Z.; Chen, M. W. One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy. Biomaterials 2018, 156, 121–133.
Chen, H.; Shou, K. Q.; Chen, S.; Qu, C. R.; Wang, Z. M.; Jiang, L.; Zhu, M.; Ding, B. B.; Qian, K.; Ji, A. et al. Smart self-assembly amphiphilic cyclopeptide-dye for near-infrared window-II imaging. Adv. Mater. 2021, 33, 2006902.
Ke, C. J.; Su, T. Y.; Chen, H. L.; Liu, H. L.; Chiang, W. L.; Chu, P. C.; Xia, Y. N.; Sung, H. W. Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments. Angew. Chem., Int. Ed. 2011, 50, 8086–8089.
Wang, B. L.; Zhang, K. B.; Wang, J. D.; Zhao, R. B.; Zhang, Q.; Kong, X. D. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy. Colloids Surf. B 2020, 189, 110832.
Fernandez, L.; Gonzalez, M.; Cerecetto, H.; Santo, M.; Silber, J. J. Solubilization and release properties of dendrimers. Evaluation as prospective drug delivery systems. Supramol. Chem. 2006, 18, 633–643.
Mei, L.; Zhu, G. Z.; Qiu, L. P.; Wu, C. C.; Chen, H. P.; Liang, H.; Cansiz, S.; Lv, Y. F.; Zhang, X. B.; Tan, W. H. Self-assembled multifunctional DNA nanoflowers for the circumvention of multidrug resistance in targeted anticancer drug delivery. Nano Res. 2015, 8, 3447–3460.
Liu, P. C.; Wu, Q.; Li, Y. M.; Li, P. F.; Yuan, J.; Meng, X. W.; Xiao, Y. H. DOX-Conjugated keratin nanoparticles for pH-Sensitive drug delivery. Colloids Surf. B 2019, 181, 1012–1018.
Xing, Z. H.; Wei, J. H.; Cheang, T. Y.; Wang, Z. R.; Zhou, X.; Wang, S. S.; Chen, W.; Wang, S. M.; Luo, J. H.; Xu, A. W. Bifunctional pH-sensitive Zn(II)-curcumin nanoparticles/siRNA effectively inhibit growth of human bladder cancer cells in vitro and in vivo. J. Mater. Chem. B 2014, 2, 2714–2724.
Rahme, K.; Dagher, N. Chemistry routes for copolymer synthesis containing PEG for targeting, imaging, and drug delivery purposes. Pharmaceutics 2019, 11, 327.
Liu, Z.; Tabakman, S.; Welsher, K.; Dai, H. J. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res. 2009, 2, 85–120.
Vila-Caballer, M.; Codolo, G.; Munari, F.; Malfanti, A.; Fassan, M.; Rugge, M.; Balasso, A.; de Bernard, M.; Salmaso, S. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment. J. Control. Release 2016, 238, 31–42.
Qiu, M.; Wang, D.; Liang, W. W.; Liu, L. P.; Zhang, Y.; Chen, X.; Sang, D. K.; Xing, C. Y.; Li, Z. J.; Dong, B. et al. Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy. Proc. Natl. Acad. Sci. USA 2018, 115, 501–506.
Yang, B. W.; Chen, Y.; Shi, J. L. Reactive oxygen species (ROS)-based nanomedicine. Chem. Rev. 2019, 119, 4881–4985.
Ferreira, C. A.; Ni, D. L.; Rosenkrans, Z. T.; Cai, W. B. Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Res. 2018, 11, 4955–4984.
Ovais, M.; Mukherjee, S.; Pramanik, A.; Das, D.; Mukherjee, A.; Raza, A.; Chen, C. Y. Designing stimuli-responsive upconversion nanoparticles that exploit the tumor microenvironment. Adv. Mater. 2020, 32, 2000055.
Chouchani, E. T.; Pell, V. R.; Gaude, E.; Aksentijević, D.; Sundier, S. Y.; Robb, E. L.; Logan, A.; Nadtochiy, S. M.; Ord, E. N. J.; Smith, A. C. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014, 515, 431–435.
Ye, M. Z.; Han, Y. X.; Tang, J. B.; Piao, Y.; Liu, X. R.; Zhou, Z. X.; Gao, J. Q.; Rao, J. H.; Shen, Y. Q. A Tumor-specific cascade amplification drug release nanoparticle for overcoming multidrug resistance in cancers. Adv. Mater. 2017, 29, 1702342.
Sun, B. J.; Luo, C.; Yu, H.; Zhang, X. B.; Chen, Q.; Yang, W. Q.; Wang, M. L.; Kan, Q. M.; Zhang, H. T.; Wang, Y. J. et al. Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy. Nano Lett. 2018, 18, 3643–3650.
Bansal, A.; Simon, M. C. Glutathione metabolism in cancer progression and treatment resistance. J. Cell Biol. 2018, 217, 2291–2298.
Xiao, Y.; Meierhofer, D. Glutathione metabolism in renal cell carcinoma progression and implications for therapies. Int. J. Mol. Sci. 2019, 20, 3672.
Cheng, R.; Feng, F.; Meng, F. H.; Deng, C.; Feijen, J.; Zhong, Z. Y. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Control. Release 2011, 152, 2–12.
Wong, D. Y. K.; Hsiao, Y. L.; Poon, C. K.; Kwan, P. C.; Chao, S. Y.; Chou, S. T.; Yang, C. S. Glutathione concentration in oral cancer tissues. Cancer Lett. 1994, 81, 111–116.
Zhu, Y. Q.; Zhang, J.; Meng, F. H.; Deng, C.; Cheng, R.; Feijen, J.; Zhong, Z. Y. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo. J. Control. Release 2016, 233, 29–38.
Li, D. D.; Zhang, R. H.; Liu, G. T.; Kang, Y.; Wu, J. Redox-responsive self-assembled nanoparticles for cancer therapy. Adv. Healthc. Mater. 2020, 9, 2000605.
Zhang, L. H.; Zhang, S. Q.; Li, M. X.; Li, Y. M.; Xiong, H. Y.; Jiang, D. G.; Li, L. J.; Huang, H.; Kang, Y.; Pang, J. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy. Mater. Sci. Eng. C 2021, 123, 111956.
Guo, H.; Xu, W. G.; Chen, J. J.; Yan, L. S.; Ding, J. X.; Hou, Y. C.; Chen, X. S. Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma. J. Control. Release 2017, 259, 136–148.
Xu, X.; Liu, K. P.; Jiao, B. B.; Luo, K. J.; Ren, J.; Zhang, G.; Yu, Q. S.; Gan, Z. H. Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer. J. Control. Release 2020, 324, 493–504.
Pan, A.; Zhang, H. Y.; Li, Y. P.; Lin, T. Y.; Wang, F. L.; Lee, J.; Cheng, M. S.; Dall'Era, M.; Li, T. H.; deVere White, R. et al. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology 2016, 27, 425103.
Guo, H.; Li, F. P.; Xu, W. G.; Chen, J. J.; Hou, Y. C.; Wang, C. X.; Ding, J. X.; Chen, X. S. Mucoadhesive cationic polypeptide nanogel with enhanced penetration for efficient intravesical chemotherapy of bladder cancer. Adv. Sci. 2018, 5, 1800004.
Kashyap, D.; Mondal, R.; Tuli, H. S.; Kumar, G.; Sharma, A. K. Molecular targets of gambogic acid in cancer: Recent trends and advancements. Tumor Biol. 2016, 37, 12915–12925.
Hortelão, A. C.; Carrascosa, R.; Murillo-Cremaes, N.; Patiño, T.; Sánchez, S. Targeting 3D bladder cancer spheroids with urease-powered nanomotors. ACS Nano 2019, 13, 429–439.
Tang, S. S.; Zhang, F. Y.; Gong, H.; Wei, F. N.; Zhuang, J.; Karshalev, E.; de Ávila, B. E. F.; Huang, C. Y.; Zhou, Z. D.; Li, Z. X. et al. Enzyme-powered Janus platelet cell robots for active and targeted drug delivery. Sci. Robot. 2020, 5, eaba6137.
Shi, J. J. Transforming platelets into microrobots. Sci. Robot. 2020, 5, eabc6582.
Choi, H.; Cho, S. H.; Hahn, S. K. Urease-powered polydopamine nanomotors for intravesical therapy of bladder diseases. ACS Nano 2020, 14, 6683–6692.
Alifu, N.; Zebibula, A.; Qi, J.; Zhang, H. Q.; Sun, C. W.; Yu, X. M.; Xue, D. W.; Lam, J. W. Y.; Li, G. H.; Qian, J. et al. Single-molecular near-infrared-II theranostic systems: Ultrastable aggregation-induced emission nanoparticles for long-term tracing and efficient photothermal therapy. ACS Nano 2018, 12, 11282–11293.
Lin, T. S.; Zhao, X. Z.; Zhao, S.; Yu, H.; Cao, W. M.; Chen, W.; Wei, H.; Guo, H. Q. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia. Theranostics 2018, 8, 990–1004.
Li, G. Z.; Yuan, S. M.; Deng, D. S.; Ou, T.; Li, Y. Q.; Sun, R.; Lei, Q. F.; Wang, X. S.; Shen, W. W.; Cheng, Y. Y. et al. Fluorinated polyethylenimine to enable transmucosal delivery of photosensitizer-conjugated catalase for photodynamic therapy of orthotopic bladder tumors postintravesical instillation. Adv. Funct. Mater. 2019, 29, 1901932.
Li, C.; Xiong, K. C.; Li, L.; Guo, Q. S.; Chen, X. L.; Madjar, A.; Watanabe, K.; Taniguchi, T.; Hwang, J. C. M.; Xia, F. N. Black phosphorus high-frequency transistors with local contact bias. ACS Nano 2020, 14, 2118–2125.
Shao, J. D.; Xie, H. H.; Huang, H.; Li, Z. B.; Sun, Z. B.; Xu, Y. H.; Xiao, Q. L.; Yu, X. F.; Zhao, Y. T.; Zhang, H. et al. Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy. Nat. Commun. 2016, 7, 12967.
Sun, R.; Liu, X. C.; Li, G. Z.; Wang, H.; Luo, Y. X.; Huang, G. X.; Wang, X. S.; Zeng, G. H.; Liu, Z.; Wu, S. Photoactivated H2 nanogenerator for enhanced chemotherapy of bladder cancer. ACS Nano 2020, 14, 8135–8148.
Pei, P.; Sun, C. Y.; Tao, W.; Li, J.; Yang, X. Z.; Wang, J. ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy. Biomaterials 2019, 188, 74–82.
Zeng, F. C.; Qin, H.; Liu, L. M.; Chang, H. C.; Chen, Q.; Wu, L. H.; Zhang, L.; Wu, Z. J.; Xing, D. Photoacoustic-immune therapy with a multi-purpose black phosphorus-based nanoparticle. Nano Res. 2020, 13, 3403–3415.
Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O.; Hahn, S. M.; Hamblin, M. R.; Juzeniene, A.; Kessel, D. et al. Photodynamic therapy of cancer: An update. CA: Cancer J. Clin. 2011, 61, 250–281.
Babič, A.; Herceg, V.; Ateb, I.; Allémann, E.; Lange, N. Tunable phosphatase-sensitive stable prodrugs of 5-aminolevulinic acid for tumor fluorescence photodetection. J. Control. Release 2016, 235, 155–164.
Li, K.; Dong, W. Y.; Qiu, L.; Liu, Q. Z.; Lv, G. G.; Peng, Y.; Xie, M. H.; Lin, J. G. A new GSH-responsive prodrug of 5-aminolevulinic acid for photodiagnosis and photodynamic therapy of tumors. Eur. J. Med. Chem. 2019, 181, 111582.
Song, X. J.; Xu, J.; Liang, C.; Chao, Y.; Jin, Q. T.; Wang, C.; Chen, M. W.; Liu, Z. Self-supplied tumor oxygenation through separated liposomal delivery of HO and catalase for enhanced radio-immunotherapy of cancer. Nano Lett. 2018, 18, 6360–6368.
Zhang, F. R.; Wu, Q. Y.; Liu, H. Y. NIR light-triggered nanomaterials-based prodrug activation towards cancer therapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2020, 12, e1643.
Gao, H.; Bi, Y.; Chen, J.; Peng, L. R.; Wen, K. K.; Ji, P.; Ren, W. F.; Li, X. Q.; Zhang, N.; Gao, J. et al. Near-infrared light-triggered switchable nanoparticles for targeted chemo/photothermal cancer therapy. ACS Appl. Mater. Interfaces 2016, 8, 15103–15112.
Gao, H.; Bi, Y.; Wang, X.; Wang, M.; Zhou, M. X.; Lu, H. R.; Gao, J. M.; Chen, J.; Hu, Y. Near-infrared guided thermal-responsive nanomedicine against orthotopic superficial bladder cancer. ACS Biomater. Sci. Eng. 2017, 3, 3628–3634.
Lentacker, I.; De Cock, I.; Deckers, R.; De Smedt, S. C.; Moonen, C. T. W. Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms. Adv. Drug Deliv. Rev. 2014, 72, 49–64.
Wang, J. F.; Zhao, Z. L.; Shen, S. X.; Zhang, C. X.; Guo, S. C.; Lu, Y. K.; Chen, Y. M.; Liao, W. J.; Liao, Y. L.; Bin, J. Selective depletion of tumor neovasculature by microbubble destruction with appropriate ultrasound pressure. Int. J. Cancer 2015, 137, 2478–2491.
Shen, S. X.; Li, Y.; Xiao, Y. B.; Zhao, Z. L.; Zhang, C. X.; Wang, J. F.; Li, H. R.; Liu, F.; He, N.; Yuan, Y. et al. Folate-conjugated nanobubbles selectively target and kill cancer cells via ultrasound-triggered intracellular explosion. Biomaterials 2018, 181, 293–306.
Ahmed, S. E.; Martins, A. M.; Husseini, G. A. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes. J. Drug Target. 2014, 23, 16–42.
Wei, P.; Sun, M.; Yang, B.; Xiao, J. G.; Du, J. Z. Ultrasound-responsive polymersomes capable of endosomal escape for efficient cancer therapy. J. Control. Release 2020, 322, 81–94.
Wang, X. W.; Zhong, X. Y.; Bai, L. X.; Xu, J.; Gong, F.; Dong, Z. L.; Yang, Z. J.; Zeng, Z. J.; Liu, Z.; Cheng, L. Ultrafine titanium monoxide (TiO1+x) nanorods for enhanced sonodynamic therapy. J. Am. Chem. Soc. 2020, 142, 6527–6537.
Wang, J.; Koo, K. M.; Wang, Y. L.; Trau, M. Engineering state-of-the-art plasmonic nanomaterials for SERS-based clinical liquid biopsy applications. Adv. Sci. 2019, 6, 1900730.
Ho, Y. J.; Wu, C. H.; Jin, Q. F.; Lin, C. Y.; Chiang, P. H.; Wu, N.; Fan, C. H.; Yang, C. M.; Yeh, C. K. Superhydrophobic drug-loaded mesoporous silica nanoparticles capped with β-cyclodextrin for ultrasound image-guided combined antivascular and chemo-sonodynamic therapy. Biomaterials 2020, 232, 119723.
Wang, H. R.; Chao, Y.; Liu, J. J.; Zhu, W. W.; Wang, G. L.; Xu, L. G.; Liu, Z. Photosensitizer-crosslinked in-situ polymerization on catalase for tumor hypoxia modulation & enhanced photodynamic therapy. Biomaterials 2018, 181, 310–317.
Theodoropoulos, V. E.; Lazaris, A.; Sofras, F.; Gerzelis, I.; Tsoukala, V.; Ghikonti, I.; Manikas, K.; Kastriotis, I. Hypoxia-inducible factor 1ɑ expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur. Urol. 2004, 46, 200–208.
Bhandari, P.; Novikova, G.; Goergen, C. J.; Irudayaraj, J. Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci. Rep. 2018, 8, 3112.
Choi, W.; Ochoa, A.; McConkey, D. J.; Aine, M.; Höglund, M.; Kim, W. Y.; Real, F. X.; Kiltie, A. E.; Milsom, I.; Dyrskjøt, L. et al. Genetic alterations in the molecular subtypes of bladder cancer: Illustration in the cancer genome atlas dataset. Eur. Urol. 2017, 72, 354–365.
Roma-Rodrigues, C.; Rivas-García, L.; Baptista, P. V.; Fernandes, A. R. Gene therapy in cancer treatment: Why go nano? Pharmaceutics 2020, 12, 233.
Kamimura, K.; Yokoo, T.; Abe, H.; Terai, S. Gene therapy for liver cancers: Current status from basic to clinics. Cancers (Basel) 2019, 11, 1865.
Hu, C.; Jiang, D. P.; Wu, M.; Wang, J.; Zhang, R. G. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer. J. Cancer Res. Clin. Oncol. 2020, 146, 1415–1426.
Yumita, N.; Nishigaki, R.; Umemura, K.; Umemura, S. I. Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn. J. Cancer Res. 1989, 80, 219–222.
Yumita, N.; Iwase, Y.; Nishi, K.; Komatsu, H.; Takeda, K.; Onodera, K.; Fukai, T.; Ikeda, T.; Umemura, S.; Okudaira, K. et al. Involvement of reactive oxygen species in sonodynamically induced apoptosis using a novel porphyrin derivative. Theranostics 2012, 2, 880–888.
Varchi, G.; Foglietta, F.; Canaparo, R.; Ballestri, M.; Arena, F.; Sotgiu, G.; Guerrini, A.; Nanni, C.; Cicoria, G.; Cravotto, G. et al. Engineered porphyrin loaded core-shell nanoparticles for selective sonodynamic anticancer treatment. Nanomedicine 2015, 10, 3483–3494.
Krasovitski, B.; Frenkel, V.; Shoham, S.; Kimmel, E. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc. Natl. Acad. Sci. USA 2011, 108, 3258–3263.
Gong, F.; Cheng, L.; Yang, N. L.; Betzer, O.; Feng, L. Z.; Zhou, Q.; Li, Y. G.; Chen, R. H.; Popovtzer, R.; Liu, Z. Ultrasmall oxygen-deficient bimetallic oxide MnWOX nanoparticles for depletion of endogenous GSH and enhanced sonodynamic cancer therapy. Adv. Mater. 2019, 31, 1900730.
Li, G. Z.; Wang, S. P.; Deng, D. S.; Xiao, Z. S.; Dong, Z. L.; Wang, Z. P.; Lei, Q. F.; Gao, S.; Huang, G. X.; Zhang, E. P. et al. Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation. ACS Nano 2020, 14, 1586–1599.
Ulbrich, K.; Holá, K.; Šubr, V.; Bakandritsos, A.; Tuček, J.; Zbořil, R. Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies. Chem. Rev. 2016, 116, 5338–5431.
Kang, T.; Li, F. Y.; Baik, S.; Shao, W.; Ling, D. S.; Hyeon, T. Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy. Biomaterials 2017, 136, 98–114.
Suo, N.; Wang, M. W.; Jin, Y.; Ding, J.; Gao, X. P.; Sun, X. L.; Zhang, H. Y.; Cui, M.; Zheng, J. L.; Li, N. L. et al. Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: An intravesical instillation system for bladder cancer. Int. J. Nanomedicine 2019, 14, 1241–1254.
Yang, W. T.; Xiang, C. Y.; Xu, Y.; Chen, S. Z.; Zeng, W. W.; Liu, K.; Jin, X.; Zhou, X.; Zhang, B. B. Albumin-constrained large-scale synthesis of renal clearable ferrous sulfide quantum dots for T1-Weighted MR imaging and phototheranostics of tumors. Biomaterials 2020, 255, 120186.
Hua, M. Y.; Yang, H. W.; Liu, H. L.; Tsai, R. Y.; Pang, S. T.; Chuang, K. L.; Chang, Y. S.; Hwang, T. L.; Chang, Y. H.; Chuang, H. C. et al. Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy. Biomaterials 2011, 32, 8999–9010.
Zakaria, M. B.; Belik, A. A.; Liu, C. H.; Hsieh, H. Y.; Liao, Y. T.; Malgras, V.; Yamauchi, Y.; Wu, K. C. W. Prussian blue derived nanoporous iron oxides as anticancer drug carriers for magnetic-guided chemotherapy. Chem. Asian J. 2015, 10, 1457–1462.
Karimi, M.; Sahandi Zangabad, P.; Ghasemi, A.; Amiri, M.; Bahrami, M.; Malekzad, H.; Ghahramanzadeh Asl, H.; Mahdieh, Z.; Bozorgomid, M.; Ghasemi, A. et al. Temperature-responsive smart nanocarriers for delivery of therapeutic agents: Applications and recent advances. ACS Appl. Mater. Interfaces 2016, 8, 21107–21133.
Wang, C.; Xu, H.; Liang, C.; Liu, Y. M.; Li, Z. W.; Yang, G. B.; Cheng, L.; Li, Y. G.; Liu, Z. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 2013, 7, 6782–6795.
Guo, J. X.; Feng, Z. J.; Liu, X.; Wang, C. R.; Huang, P. S.; Zhang, J. H.; Deng, L. D.; Wang, W. W.; Dong, A. J. An injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy. Soft Matter 2020, 16, 5750–5758.
Xu, Y. W.; Xu, Y.; Bi, B.; Hou, M. J.; Yao, L.; Du, Q. R.; He, A. J.; Liu, Y.; Miao, C. L.; Liang, X. Q. et al. A moldable thermosensitive hydroxypropyl chitin hydrogel for 3D cartilage regeneration in vitro and in vivo. Acta Biomater. 2020, 108, 87–96.
Chen, J. P.; Leu, Y. L.; Fang, C. L.; Chen, C. H.; Fang, J. Y. Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin. J. Pharm. Sci. 2011, 100, 655–666.
Men, K.; Liu, W.; Li, L.; Duan, X. M.; Wang, P.; Gou, M. L.; Wei, X. W.; Gao, X.; Wang, B. L.; Du, Y. et al. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Nanoscale 2012, 4, 6425–6433.
Shen, H. X.; Shi, S. J.; Zhang, Z. R.; Gong, T.; Sun, X. Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells. Theranostics 2015, 5, 755–771.
He, Y. Y.; Nie, Y.; Cheng, G.; Xie, L.; Shen, Y. Q.; Gu, Z. W. Viral mimicking ternary polyplexes: A reduction-controlled hierarchical unpacking vector for gene delivery. Adv. Mater. 2014, 26, 1534–1540.
Zhong, Y.; Goltsche, K.; Cheng, L.; Xie, F.; Meng, F. H.; Deng, C.; Zhong, Z. Y.; Haag, R. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials 2016, 84, 250–261.
Zhu, Y. T.; Zhao, Z.; Fu, X. Y.; Luo, Y.; Lei, C. Y.; Chen, W.; Li, F.; Pang, S. Y.; Chen, S. S.; Tan, W. L. The granulocyte macrophage-colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer. Stem Cell Res. 2014, 13, 111–122.
Lin, T. S.; Yuan, A. H.; Zhao, X. Z.; Lian, H. B.; Zhuang, J. L.; Chen, W.; Zhang, Q.; Liu, G. X.; Zhang, S. W.; Chen, W. et al. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer. Acta Biomater. 2017, 53, 427–438.
Xu, C. C.; Li, H.; Zhang, K. M.; Binzel, D. W.; Yin, H. R.; Chiu, W.; Guo, P. X. Photo-controlled release of paclitaxel and model drugs from RNA pyramids. Nano Res. 2019, 12, 41–48.
Xu, Y.; Zhai, X.; Su, P.; Liu, T. Q.; Zhou, L. Y.; Zhang, J. J.; Bao, B. Q.; Wang, L. H. Highly stable semiconducting polymer nanoparticles for multi-responsive chemo/photothermal combined cancer therapy. Theranostics 2020, 10, 5966–5978.
Lin, L. T.; Gong, H. Y.; Li, R.; Huang, J. J.; Cai, M. Y.; Lan, T.; Huang, W. S.; Guo, Y. J.; Zhou, Z. M.; An, Y. C. et al. Nanodrug with ROS and pH dual-sensitivity ameliorates liver fibrosis via multicellular regulation. Adv. Sci. 2020, 7, 1903138.
Zhao, N.; Ding, B. B.; Zhang, Y.; Klockow, J. L.; Lau, K.; Chin, F. T.; Cheng, Z.; Liu, H. G. Reactive oxygen species and enzyme dual-responsive biocompatible drug delivery system for targeted tumor therapy. J. Control. Release 2020, 324, 330–340.
Yu, Q. L.; Deng, T.; Lin, F. C.; Zhang, B.; Zink, J. I. Supramolecular assemblies of heterogeneous mesoporous silica nanoparticles to co-deliver antimicrobial peptides and antibiotics for synergistic eradication of pathogenic biofilms. ACS Nano 2020, 14, 5926–5937.
Zhang, D.; Sun, P.; Li, P.; Xue, A. B.; Zhang, X. K.; Zhang, H. Y.; Jin, X. B. A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer. Biomaterials 2013, 34, 10258–10266.
Lee, H.; Dellatore, S. M.; Miller, W. M.; Messersmith, P. B. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007, 318, 426–430.
Liu, Y. L.; Ai, K. L.; Liu, J. H.; Deng, M.; He, Y. Y.; Lu, L. H. Dopamine-melanin colloidal nanospheres: An efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv. Mater. 2013, 25, 1353–1359.
Poinard, B.; Neo, S. Z. Y.; Yeo, E. L. L.; Heng, H. P. S.; Neoh, K. G.; Kah, J. C. Y. Polydopamine nanoparticles enhance drug release for combined photodynamic and photothermal therapy. ACS Appl. Mater. Interfaces 2018, 10, 21125–21136.
Tan, J.; Sun, C. Y.; Xu, K.; Wang, C. C.; Guo, J. Immobilization of ALA-ZnII coordination polymer pro-photosensitizers on magnetite colloidal supraparticles for target photodynamic therapy of bladder cancer. Small 2015, 11, 6338–6346.
京公网安备11010802044758号